Aceclofenac 100 mg & Drotaverine HCl 80 mg Film-Coated Tablets

Formulated to address both pain and smooth-muscle contractions, these film-coated tablets combine Aceclofenac (100 mg) and Drotaverine Hydrochloride (80 mg) in one convenient formulation. Each tablet contains the two active ingredients in the stated strengths, bringing an anti-inflammatory medicine and an antispasmodic medicine together in a single oral presentation. Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) that helps reduce pain and inflammation, while Drotaverine provides antispasmodic relief by relaxing smooth muscles. By bringing these two active ingredients together in a single tablet, the formulation is intended for situations where pain occurs alongside muscle spasm. It may be suitable for conditions involving pain accompanied by muscle spasm, including musculoskeletal pain and abdominal cramping. The relevance of this combination depends on the cause of the symptoms and the individual's circumstances, and not every type of pain or cramping will be appropriate for this product. The film-coated tablet format offers a convenient oral presentation, while the clearly specified strengths make the amount of each active ingredient easy to identify. The product is packaged in a 10 × 10 Blister/Alu-Alu presentation, providing a practical format for storage and dispensing. The combination of an anti-inflammatory ingredient and an antispasmodic ingredient is designed to address these different symptoms within one formulation; however, the suitability and expected benefits can vary from person to person. The product information should be checked carefully to confirm the ingredients, strengths, and directions before use. Use should be guided by the product labeling and the advice of a qualified healthcare professional. Before use, patients should review the product information and tell their healthcare professional about relevant medical conditions, allergies, and other medicines or supplements they are taking. This is especially important if they have previously experienced a reaction to an NSAID or are using other products that may contain similar ingredients. Patients should also raise any questions about whether this combination is appropriate for them, including questions related to their health history or current treatment. The appropriate use of this combination may depend on the individual's symptoms and health history, so it should not be used as a substitute for professional assessment. Follow the directions provided on the label or by a qualified healthcare professional, and do not exceed the recommended instructions. Do not change how the product is taken or combine it with other medicines without first checking with a healthcare professional when in doubt. Do not assume that taking more will provide greater benefit, and seek professional guidance if the directions are unclear. If symptoms persist, worsen, or are accompanied by concerning signs, seek medical advice. A healthcare professional can help determine whether further assessment or a different approach is appropriate. If an unexpected reaction or other concern occurs while using the product, consult a healthcare professional and follow the product information. Store the tablets as directed on the packaging and keep them out of the reach of children. Keep the tablets in their original packaging where possible, and do not use them if the packaging is damaged or the product is past its stated expiry date. Check the packaging before use to ensure that the product and its instructions are clear, and ask a pharmacist or other qualified healthcare professional if any information needs clarification.